Formulation of a Thienopyridine Platelet Aggregation Inhibitor
AssigneeEli Lilly and Company
InventorsDavid Brian Dziennik, Tamara Beth Edelman, Peter Lloyd Oren, Robert Louis Ternik
Life of this patent
Estimating the term…
Abstract
A formulation of a compound of formula (I) process of manufacture and methods of using it are disclosed.
Claims18
A formulation comprising a therapeutically effective amount of the compound of formula I
- packaged in an air and moisture impervious gas-inerted blister pack.
Use of a formulation of the compound of formula I comprising administering a therapeutically effective amount of a tablet, caplet, capsule or other solid formulation of the compound of formula I which has been packaged in an air and moisture impervious gas-inerted blister pack for the treatment and/or prevention of thrombosis, acute coronary syndrome, ACS-MM, stroke, cerebrovascular aneurysyms, and high risk vascular diseases.
A method of improving the stability and shelf life of the compound of formula I comprising packaging tablet(s), caplet(s) or capsule(s) of the compound of formula I in gas-inerted aluminum foil blister pack(s).
(canceled)
A process for the manufacture of a compound of formula I comprising the steps of:
- a. preparing tablets, caplets or capsules of the compound of formula I, and
- b. packaging said tablets, caplets, capsules or other solid formulation of the compound of formula I in gas inerted blister packs.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.